HCWB
HCW Biologics·NASDAQ
--
--(--)
--
--(--)
3.83 / 10
Netural
Capital flow assessment yields 7.67/10, denoting robust fund flow characteristics. Strengths in Small trends confront pressures from overall, block, Medium, Large, and Extra-large patterns, resulting in positive liquidity outlook. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(100.0%) representing 1 analyst views, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-29
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for HCWB?
- HCWB holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.83/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
